Breastfeeding Accessories Market Revenue is Expected to Reach $2.55 Billion by 2026

The global breastfeeding accessories market size is expected to reach USD 2.55 billion by 2026 expanding at a CAGR of 7.8%, according to a new report by Grand View Research, Inc. Increasing women employment is expected to be one of the major factors boosting the market growth. For instance, as per the World Bank, female employment in South Africa has increased from 44.99% in 2015 to 45.07% in 2017. Decreasing infant mortality rate is likely to drive the market further. As per the statistics reported by the United Health Foundation, the infant mortality rate in U.S. declined from 6.0% in 2016 to 5.9% in 2018.

The market in developed economies, such as U.S., Germany, France, and Australia, is comparatively matured owing to the presence of key companies and high demand for such products. On the other hand, developing Asian and Latin American countries currently have a moderate demand due to low awareness levels about these products. Moreover, higher popularity of formulae feeding over breastfeeding in countries, such as China, is also responsible for slow market growth in developing regions. However, various government initiatives aimed at spreading awareness about breastfeeding and related accessories along with economic growth and rising disposable income levels in these countries are anticipated to propel the growth in near future.

Access Research Report of Breastfeeding Accessories Market @
https://www.grandviewresearch.com/industry-analysis/breastfeeding-accessories-market

Further key findings from the study suggest:

• Nipple care products are projected to witness a significant growth over the forecast years owing to huge demand for nipple shields, especially in U.S.
• Asia Pacific is estimated to witness the highest CAGR of 9.9% over the estimated period due to increased female employment disposable income along with high penetration of pumping technology
• North America commanded the highest share in the global breastfeeding accessories market in 2018 due to awareness about such accessories and developed healthcare infrastructure
• Some of the key companies in the market are Koninklijke Philips N.V., Medela LLC, Mayborn Group Limited, Artsana S.p.A., Edgewell Personal Care, And Handi-Craft Company (Dr. Brown’s)

Grand View Research has segmented the global breastfeeding accessories market on the basis of product and region:

Breastfeeding Accessories Product Outlook (Revenue, USD Million, 2015 - 2026)

• Nipple Care Products
• Breast Shells
• Breast Pads
• Baby Scales
• Breastmilk Preparation & Cleaning Products
• Breastmilk Storage & Feeding
• Other Accessories

Breastfeeding Accessories Region Outlook (Revenue, USD Million, 2015 - 2026)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Greece
  • Switzerland
  • Spain
  • Italy
  • Netherlands
  • France
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
  • Malaysia
  • Russia
  • Hong Kong
  • Vietnam
  • New Zealand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Costa Rica
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Oman
  • Egypt

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Artificial Insemination Market Top Players ,Analysis And Forecast Till 2026

The global artificial insemination market size is expected to reach USD 2.9 billion by 2026 registering a CAGR of 8.4%, according to a new report by Grand View Research, Inc. Over the past few years, infertility has become a major public health concern across the globe. Artificial insemination is usually the preferred first-line treatment to tackle infertility. Lifestyle changes, delay in pregnancy, and hormonal issues are some of the reasons contributing to the rise in fertility-related problems. According to the United Nations, the global fertility rate is expected to decline to 2.2% by 2050. In developing or underdeveloped nations, medical consultation regarding infertility was not easily accessible.

Hence, there was a lack of awareness about available assisted reproductive techniques including artificial or donor insemination and IVF. The average cost of performing an IUI is around USD 865. The success rate for each cycle is around 4 to 5%, which can be increased to about 7 to 16% by consuming fertility drugs. However, older women are not encouraged to go through IUI due to slim chances of success and further complications. Several fertility problems can be addressed through IUI, such as semen allergy, unexplained infertility, and Sexually Transmitted Diseases (STDs).

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/artificial-insemination-market

Further key findings from the study suggest:

• Artificial insemination is a first-line of infertility treatment, as it is minimally invasive and less expensive as compared to IVF
• In some countries, such as U.S. and U.K., same-sex couples are provided insurance coverage for artificial insemination procedures
• Intrauterine insemination held majority of the market share in 2018 and is likely to be the fastest-growing segment over the forecast period as it is the most common and non-invasive procedure
• Fertility clinics held a majority of the market share in the year 2018 due to higher number of medical facilities offering infertility treatments
• Europe held a majority of the market share in the year 2018. North America was the second-largest market in 2018
• Some of the key companies in the global artificial insemination market include Vitrolife; Genea Ltd.; Rinovum Women’s Health, LLC; Pride Angel; Hi-Tech Solutions; FUJIFILM Irvine Scientific; Kitazato Corp.; and Rocket Medical plc

Grand View Research has segmented the global artificial insemination market on the basis of type, end use, source type, and region:

Artificial Insemination Type Outlook (Revenue, USD Million, 2015 - 2026)

• Intrauterine
• Intracervical
• Intravaginal
• Intratubal

Artificial Insemination End Use Outlook (Revenue, USD Million, 2015 - 2026)

• Fertility Clinics & Other Facilities
• Home

Artificial Insemination Source Type Outlook (Revenue, USD Million, 2015 - 2026)

• AIH-Husband
• AID-Donor

Artificial Insemination Regional Outlook (Revenue, USD Million, 2015 - 2026)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Attention Deficit Hyperactivity Disorder Market Estimated to Experience a Hike in Growth by 2025

The Report Attention Deficit Hyperactivity Disorder (ADHD) Market Analysis Report By Drug Type (Stimulant, Non-stimulant), By Demographic, By Distribution Channel (Hospital & Retail Pharmacy), And Segment Forecasts, 2019 - 2025

The global attention deficit hyperactivity disorder market size is expected to reach USD 24.9 billion by 2025, based on a new report by Grand View Research, Inc., exhibiting a 6.4% CAGR during the forecast period. Increase in awareness regarding ADHD among patients, physicians, and other healthcare providers is likely to up demand for effective treatment, in turn, propelling market growth.

Furthermore, there has been a steady rise in ADHD patients during the last 20 years. According to a study conducted by the National Health Interview Survey, the prevalence of ADHD among children and adolescents in U.S. rose from 6.1% in 1997-1998 to 10.2% in 2015-2016.

Approval and commercialization of drugs, increase in number of clinical trials, and rise in awareness regarding diagnosis and treatment of the condition is expected to boost market growth over the forecast period.

Access Research Report of ADHD Market@ https://www.grandviewresearch.com/industry-analysis/attention-deficit-hyperactivity-disorder-adhd-market

Further key findings from the study suggest:

• Increasing access to health insurance for mental health treatment and rising incidence of ADHD are expected to propel market growth in the coming years
• By drug type, the stimulant drugs segment accounted for the largest share in the market in 2018 and is anticipated to maintain its dominance during the forecast period. This can be attributed to effectiveness of drugs in treating of ADHD symptoms and commercialization of new drugs
• Based on demographics, adults held the maximum share in the ADHD market in 2018 due to high prevalence of the condition across the globe, increased awareness about mental health, and launch of effective drugs with minimum adverse effects
• By distribution channel, retail pharmacy accounted for the largest share in 2018 due to increasing number of prescriptions. This can be attributed to rise in patient care initiatives by retail pharmacies
• Geographically, North America dominated the global ADHD market in 2018 owing to high awareness of mental health, increasing patient population, and local presence of market players
• Asia Pacific is anticipated to observe significant growth during the forecast period owing to government initiatives to provide effective treatment for ADHD and rising patient population due to stressful lifestyle
• Some of the key players in the market are Eli Lily & Company; Pfizer; Johnson & Johnson Services, LLC; Lupin; Shire; Mallinckrodt; Prude Pharma L.P.; and NEOS Therapeutics Inc.

Grand View Research has segmented the global ADHD market by drug type, demographic, distribution channel, and region:

ADHD Drug Outlook (Market Revenue in USD Million, 2014 - 2025)

• Amphetamine
• Methylphenidate
• Lisdexamfetamine
• Dexmethylphenidate
• Atomoxetine
• Guanfacine
• Clonidine
• Bupropion

ADHD Drug Type Outlook (Market Revenue in USD Million, 2014 - 2025)

• Stimulant
• Non-stimulant

ADHD Demographic Outlook (Market Revenue in USD Million, 2014-2025)

• Adult (Aged 18 and above)
• Children

ADHD Distribution Channel Outlook (Market Revenue in USD Million, 2014-2025)

• Retail Pharmacy
• Hospital Pharmacy

ADHD Regional Outlook (Market Revenue in USD Million, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Bipolar Disorder Market Competitive Insight and Key Drivers by 2025

The global bipolar disorder market is anticipated to reach USD 4.9 billion by 2025, growing at a CAGR of 2.10%, according to a new report by Grand View Research, Inc. Government support for generating awareness about the bipolar disorder and technological advancements that facilitate accurate detection of a patient’s mood and mental state are a few of the factors driving the growth of this market.

The rising prevalence of bipolar disorders is likely to propel market growth in the forecast period. Government initiatives also drive the market growth. For instance, International Bipolar Foundation’s Social Security Disability Insurance (SSDI) or Supplemental Security Income (SSI) are programs offered by the Social Security Administration (U.S.) for the benefit of the people affected by bipolar disorder.

Besides, technological advancements in smartphones, smartwatches, and wearable devices improve diagnosis rates by capturing physiological, behavioral, and environmental data effectively to detect the patient’s mood and mental state. Online self-management tools also result in timely intervention, thereby improving diagnosis rates and treatment rates for the disorder. However, the patent expiry of blockbuster drugs in this market is likely to impact market dynamics in the forecast period. Additionally, the drugs in the bipolar disorder market are bound to face intense competition from generic drugs, as treatment options for bipolar disorder. Other factors likely to restrain market growth in the forecast period include side effects associated with bipolar drugs, and misdiagnosis of bipolar disorder.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/bipolar-disorder-market

Further Key Findings From the Study Suggest:

• The antipsychotic segment is expected to dominate the market owing to increasing prevalence of psychosis, and physical illness resulting in depression.
• The serotonin norepinephrine reuptake inhibitor segment is anticipated to dominate the market in the forecast period. The growth of this segment is due to these drugs being primarily used to treat major depression and bipolar disorder, and having better safety profile and tolerability.
• North America is expected to dominate global bipolar disorder market. This can be attributed to the high stress levels, insufficient sleep, and trend of substance abuse amongst the population.
• Some of the major players in this space include GlaxoSmithKline (GSK), Pfizer Inc., Janssen Pharmaceuticals, Eli Lilly, Allergan Plc., Novartis AG, AbbVie Inc., Otsuka Holdings Co. Ltd, and AstraZeneca.

Grand View Research has segmented the global bipolar disorder market on the basis of drug class, mechanism of action, and region:

Drug Class Outlook (Revenue, USD Million, 2014 - 2025)

• Mood stabilizer
• Anticonvulsant
• Antipsychotic drugs
• Antidepressant drugs
• Antianxiety drugs

Mechanism of Action Outlook (Revenue, USD Million, 2014 - 2025)

• Selective serotonin reuptake inhibitor
• Serotonin norepinephrine reuptake inhibitor
• Tricyclic antidepressants
• Monoamine oxidase inhibitors
• Benzodiazepines
• Beta blockers
• Others

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
  • France
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Animal Health Market Will Target Emerging Markets by 2027

Animal Health Market Growth & Trends

The global animal health market size is expected to reach USD 73.6 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 5.8% over the forecast period. The market is driven by technological advancements in veterinary care, which are anticipated to offer the market future growth opportunities. For instance, MediLabSecure, a laboratory network project (2014-2021), was initiated with an aim of identifying emerging viruses and pathogens in 19 countries in the Mediterranean regions. In addition, emergence of veterinary health information systems, specifically in developed economies, is expected to provide high growth potential in future.

With the help of these systems, data generated in veterinary clinics can be uploaded on the internet, which can be further shared with other researchers and clinicians. Incorporation of this technology will facilitate real-time analysis for fluctuations in disease prevalence. As a consequence of the aforementioned factors, it is presumed that there will be significant improvement in the overall penetration rate of veterinary health products, which is anticipated to fuel market demand as well as revenue.

North America captured substantial share in the global market in 2019, owing to a wide range of definitive measures adopted by welfare organizations, technological advancements, rising incidence of zoonotic diseases, and increasing number of pet owners. Asia Pacific is expected to exhibit lucrative growth over the coming years as consequence of consistent R&D investments deployed by prominent players and their efforts to commercialize branded and generic therapeutics at a relatively inexpensive price.

Key market participants employ sustainability strategies, such as expanding product portfolio, to gain competitive advantage. For instance, in April 2019, Merck acquired Antelliq Corporation operational in the field of digital animal identification, traceability, and monitoring solutions. This acquisition helped the company improve its veterinary vaccines and pharmaceutical solutions portfolio.

Request a free sample copy or view report summary: Animal Health Market Report

Animal Health Market Report Highlights

• By product, vaccines are expected to exhibit lucrative growth due to significant increase in the adoption of pets, which demands long-term health plans
• Based on animal type, the companion animal segment is anticipated to grow at an exponential rate owing to associated health benefits for humans such as lower blood pressure, greater psychological stability, and reduced anxiety attacks
• By distribution channel, retail channels and e-commerce platforms accounted for a notable share owing to factors such as convenience associated with online pharmacies and increasing number of retail pharmacies
• Point-of testing is fastest growing end-use segment due to increase in demand for highly productive animals and growing investments in R&D for novel animal products
• In 2019, North America accounted for the largest share in the global animal health market owing to local presence of established pharmaceutical companies, consistently striving for extensive commercialization of their products
• Asia Pacific is anticipated to grow at a steady rate as a consequence of high clinical urgency to curb incidence of zoonotic diseases and management of disease outbreaks, such as swine influenza and Ebola.

Animal Health Market Segmentation

Grand View Research has segmented the global animal health market on the basis of animal type, product, distribution channel, end use, and region:

Animal Health Animal Type Outlook (Revenue, USD Million, 2016 - 2027)

• Companion Animal
  • Dogs
  • Cats
  • Horses
  • Others
• Production Animal
  • Poultry
  • Swine
  • Cattle
  • Sheep & Goats
  • Fish

Animal Health Product Outlook (Revenue, USD Million, 2016 - 2027)

• Vaccines
  • Live Attenuated Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • Inactivated Vaccines
  • Others
• Pharmaceuticals
  • Live Attenuated Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • Inactivated Vaccines
  • Others
• Feed Additives
  • Nutritional
  • Medicinal
• Diagnostics
  • Instruments
  • Consumables
• Others

 Animal Health Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)

• Retail
• E-commerce
• Veterinary Hospitals & Clinics

Animal Health End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Reference Laboratories
• Point-of-care Testing/In-house Testing
• Veterinary Hospitals & Clinics
• Others

Animal Health Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Russia
  • Spain
  • Netherlands
  • Switzerland
  • Sweden
  • Ireland
  • Poland
• Asia Pacific
  • Japan
  • China
  • India
  • Indonesia
  • Thailand
  • Australia
  • South Korea
  • Philippines
  • Malaysia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Turkey
  • Iran
  • United Arab Emirates
  • Israel

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Device Analytical Testing Outsourcing Market to Expand with Significant CAGR During 2018 – 2025

The global medical device analytical testing outsourcing market size is expected to reach USD 8.3 billion by 2025, according to a new report by Grand View Research, Inc. A large number of medical device companies outsource analytical testing operations to minimize business risks, hasten product market entry, and reduce costs. These lead to significant rise in expenditure levels and, therefore, medical device original equipment manufacturers rapidly switch to outsourcing as one of the effective cost curbing tool.

Implantable Medical Devices (IMDs) are being used increasingly in order to improve patients’ health outcome. Designers of IMDs have to balance complexity, reliability, power consumption, and costs. Consequently, companies are shifting their focus to innovation rather than noncore activities and, therefore, outsourcing these activities to launch efficient devices. All these factors are expected to increase the medical device outsourcing market over the forecast period.

In this complex ecosystem, it is necessary for equipment to provide accurate results, to have durability, and easy operation. To match these parameters, devices now have to undergo shear testing in accelerated conditions to obtain marketing approval and have competitive advantage. Conducting these in-house is matter of time, labor, and cost; outsourcing these tests helps overcome these limitations.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/medical-device-analytical-testing-outsourcing-market

Further key findings from the study suggest: 

• Material characterization dominated the medical device analytical testing outsourcing market in 2015 and is likely to grow at a lucrative rate during the forecast period
• Other tests that are inclusive of cleaning, reprocessing, method development & validation, accelerated stability testing, biocompatibility, validation testing for packaging materials (container closure permeation), and transport stability are also anticipated to witness rewarding growth.
• North America is likely to witness lucrative growth which is attributed to the fact that it is one of the top manufacturing hubs of highly reliable, complex, and high-end medical devices.
• Some of the key players operating in this space are SGS SA; Toxikon, Inc.; Eurofins Scientific; Pace Analytical Services, LLC; Intertek Group plc; WuXi AppTec.; NORTH AMERICAN SCIENCE ASSOCIATES INC.; Envigo; Charles River Laboratories International Inc.; and Medical Device Testing Services

Grand View Research has segmented the global medical device analytical testing outsourcing market on the basis of services and region:

Medical Device Analytical Testing Outsourcing Services Outlook (Revenue, USD Million, 2014 - 2025)

• Extractable & Leachable
• Material Characterization
• Physical Testing
• Bioburden Testing
• Others

Medical Device Analytical Testing Outsourcing Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pharmaceuticals Analytical Testing Outsourcing Market Expected to Witness a Sustainable Growth over 2027

The global pharmaceutical analytical testing outsourcing market size is expected to reach USD 11.4 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 8.3% over the forecast period. Increasing pipelines for biological candidates, rising demand for additional analytical details on drugs, and process development by regulatory agencies are boosting the market growth.

Analytical testing helps in providing real-time product quality control along with optimizing and monitoring processes, characterizing biosimilars and biologics, and improving productivity. One of the main reasons for outsourcing analytical testing services is to benefit from skilled and experienced professionals, as well as to access expensive analytical equipment which are not available in-house.

Increased development of biologics is also creating a demand for analytical testing services. In the last three decades, biologics have taken the center stage in the discovery and development of drugs. Moreover, there is a high demand to define higher-order biological structures. The need for better product characterization, along with comparability studies, especially for biosimilars, further leads to drug companies outsourcing these services.

A patent cliff, particularly for small molecules in the pharmaceutical industry leads to a decline in revenue, thereby affecting profits. Over the next few years, several best-selling biologics would come toward the end of patent life, such as Humira. Drug innovators are therefore under constant pressure to bring new products through the pipeline at a faster rate. Developing advanced analytical testing to assess and monitor the quality attributes of these products requires a broader set of equipment and expertise, which is beyond the internal capacity of pharma companies. This would subsequently lead to increased instances of outsourcing pharmaceutical analytical testing services.   

Access Research Report of Pharmaceuticals Analytical Testing Outsourcing Market @ https://www.grandviewresearch.com/industry-analysis/pharmaceutical-analytical-testing-outsourcing-market

Further key findings from the report suggest:

• The outsourcing of clinical bioanalytical testing services emerged as the largest segment in 2019 with a share of around 79% owing to the increasing number of clinical trials
• The extractable and leachable services segment is expected to witness a significant growth rate owing to an increasing number of vendors offering these services at competitive prices
• North America dominated the global market with a share of 54.2% in 2019 as the region is one of the top manufacturing hubs of highly reliable, complex, and high-end pharmaceuticals
• Some of the players operating in the pharmaceutical analytical testing outsourcing market are Toxikon, Inc.; Intertek Group PLC; SGS SA; Eurofins Scientific; Boston Analytical; Pace Analytical Services, LLC; West Pharmaceutical Services, Inc.; Intertek Group Plc; Pharmaceutical Product Development, LLC; WuXi AppTec, Inc.; and Charles River Laboratories International, Inc.          

Grand View Research has segmented the global pharmaceutical analytical testing outsourcing market on the basis of service and region:

Pharmaceutical Analytical Testing Outsourcing Service Outlook (Revenue, USD Million, 2016 - 2027)

• Bioanalytical Testing
  • Clinical
  • Non Clinical
• Method Development & Validation
  • Extractable & Leachable
  • Impurity Method
  • Technical Consulting
  • Others
• Stability Testing
  • Drug Substance
  • Stability Indicating Method Validation
  • Accelerated Stability
  • Photostability
  • Others
• Others

Pharmaceutical Analytical Testing Outsourcing Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Turkey
  • Netherlands
  • Switzerland
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Malaysia
  • Singapore
  • Thailand
  • Taiwan
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Israel

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Animal Genetics Market Will Target Emerging Markets By 2026

Animal Genetics Market Growth & Trends

The global animal genetics market size is expected to reach USD 8.9 billion by 2026, according to a new report by Grand View Research, Inc. exhibiting a CAGR of 4.9%. The market for animal genetics is anticipated to witness rise in demand owing to factors such as increasing consumption of animal proteins and rapid global urbanization. To fulfill the continuously rising demand, the preference for genetics to breed high-quality livestock and secure large production has increased. The demand for animal genetics has increased over the years, owing to rise in various animal diseases, increasing prevalence of zoonotic diseases, and rise in adoption of pets & companion animals.

According to Food and Agriculture Organization (FAO) publication 2017, livestock contributes almost 40% to the global value of agricultural output, and it supports food security and livelihood of more 1.5 billion people worldwide. However, the increasing land requirement for these animals and grazing is a major environmental concern. Public awareness regarding such concerns is a major reason leading to the shift toward white meat and vegan lifestyle, impeding growth of animal genetics. However, increasing support and research by government organizations to improve productivity is aiding growth. For instance; Animal Improvement Program Launched in 2014, by Animal Genomics and Improvement Laboratory (AGIL), which is an agricultural research service organization of USDA. The program aims at improving productivity and efficiency of dairy animals & ruminants.

The market follows the standards set by International Society of Animal Genetics (ISAG) and leading animal research laboratories such as The University of California Davis (U.C. Davis). The ISAG standard panel consists of 18 STR markers, and any company in animal genetics needs to follow the panel and standards set by the authorities. The need for high investments in development of new technology and the duration of product launch are some of the major factors resulting in steady growth. However, increasing population is expected to pose an ongoing challenge due to rise in the need for animal protein, aiding developments in the market.

Request a free sample copy or view report summary: Animal Genetics Market Report

Animal Genetics Market Report Highlights

• Porcine segment was the largest revenue-generating segment in 2018, owing to increasing consumption of pig meat in the European countries
• The embryo segment accounted for the largest revenue share, based on genetic material, in 2018, owing to the large numbers of embryos produced and sold in countries such as France, Canada, Brazil, and Spain
• In the services segment, the genetic diseases testing segment accounted for the largest share in 2018 and is expected to maintain its dominance throughout the forecast period
• The North American animal genetics market is the leading region and accounted for the largest revenue share in 2018, mainly due to existence of significant number of research and development activities in the region
• The Asia Pacific region is expected to grow at the highest rate during the study period. Growing population coupled with increasing demand for animal protein is a major factor aiding regional growth
• Some of the major players are Genus Plc; Envigo Corporation; Topigs Norsvin; CRV Holding B.V; Groupe Grimaud La Corbiere SA; Hendrix Genetics BV; Neogen Corporation; Zoetis, Inc; URUS; and Animal Genetics, Inc.

Animal Genetics Market Segmentation

Grand View Research has segmented the global animal genetics market on the basis of live animals, genetic material, services, and region:

Animal Genetics Live Animals Outlook (Revenue, USD Million, 2014 - 2026)

• Porcine
• Bovine
• Poultry
• Canine
• Others

Animal Genetics Genetic Material Outlook (Revenue, USD Million, 2014 - 2026)

• Embryo
• Semen

Animal Genetics Service Outlook (Revenue, USD Million, 2014 - 2026)

• Genetic Trait Testing
• Genetic Diseases Testing
• DNA Typing

Animal Genetics Regional Outlook (Revenue, USD Million, 2014 - 2026)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Demand for Medical Marijuana Market to Incur Considerable Upsurge During 2018 – 2025

The global medical marijuana market is expected to reach a value of USD 55.8 billion by 2025, according to a new report by Grand View Research, Inc. It has been identified that, in 2016, Washington D.C. along with 28 states have legalized marijuana for medical uses. In 2016, states such as Arkansas, Florida, North Dakota, Ohio, and Pennsylvania were approved to use the drug in medical applications such as chemotherapies and pain management. The growing number of states and countries getting approval for using it in therapeutic applications is one of the crucial factors driving the demand over the coming few years.

The presence of several regulatory frameworks such as the Medical Marijuana Regulation and Safety Act is indicators of the present demand for the drug in the market. The regulatory framework requires every individual or the company associated such as growers, retail operators, and makers of processed pot products to obtain permission and an annual state license from 2018. An increasing number of issued licenses is also among factors that is expected to drive the market especially after 2018.

The increasing interest amongst the academic researchers and healthcare providers regarding the therapeutic uses of marijuana is among the significant factors, which is driving the market over the coming years. Some of its potential therapeutic values are suppression of vomiting & nausea, pain relief, and appetite stimulation. In addition, research states that marijuana is effective in providing relief to the patient suffering from HIV/AIDS, glaucoma, cancer, and multiple sclerosis. The growing number of therapeutic applications of the drug is one of the key factors that is propelling the market over the forecast period.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/medical-marijuana-market

Further key findings from the study suggest:

• In 2015, chronic pain was the largest application segment owing to the presence of a huge patient base
• The growing prevalence of chronic pain elevates the demand for the drug, thus expected to boost the medical marijuana for chronic pain management
• The rapidly growing number of cannabis legalization in the U.S. is one of the key attributes for its increased demand in therapeutic and recreational uses, and thus anticipated to impel the market growth
• Increasing investment in R&D & demand for cannabis in chemotherapy is expected to drive the growth in the Asia Pacific market
• Some of the key players are Cara Therapeutics Inc.; CannaGrow Holdings, Inc.; Cannabis Sativa, Inc.; United Cannabis Corporation; GrowBlox Sciences, Inc.; GW Pharmaceuticals, plc; Lexaria Corp; International Consolidated Companies, Inc.

Grand View Research has segmented the medical marijuana market by application and region:

Application Outlook (Market Revenue in USD Million, 2013 - 2025)

• Chronic Pain
• Arthritis
• Migraine
• Cancer
• Others

Regional Outlook (Market Revenue in USD Million, 2013 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Belgium
  • Croatia
  • Finland
  • France
  • Italy
  • Netherlands
  • Portugal
  • Romania
  • Switzerland
  • Czech Republic
  • Estonia
• ROW
  • Israel

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Radiation Dose Monitoring Market Strong Application and Emerging Trends also Scope by 2025

Global radiation dose monitoring market size is anticipated to reach a value of USD 3.9 billion by 2025, according to a new report by Grand View Research, Inc. The advantage of automated dose monitoring systems to track individual and cumulative radiation dose exposure in patients is driving significant demand for the product.

Dose monitoring is achieved by the use of software and designated products such as dosimeters. Dose management software analyzes, identifies, and optimizes radiation dose performance with precise data. This data aids the physicians to provide quality care to the patients. Furthermore, easy integration of software into existing medical architecture of hospitals will boost the value of existing medical systems and ensure safety of using them.

Area of application commonly employing the use of medical imaging is radiography, angiography, mammography, fluoroscopy & interventional imaging and nuclear medicine. Several medical imaging technology manufacturers are constantly involving in the incorporation of the radiation dose monitoring tools in these imaging platforms. X-ray and computed tomography technique are known to emit a large amount of radiation as compared to other imaging platforms. The overall market exhibits promising growth prospects pertaining to high prevalence of chronic diseases, effective and reliable treatment methods focusing on care, and increasing patient awareness.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/radiation-dose-monitoring-market

Further key findings from the study suggest:

• North America reported highest revenue growth in this market in 2015. A shift to the value based care delivery model has resulted in healthcare providers to divert their attention to deliver healthcare services concentrating on the well-being of a patient
• Asia Pacific region provides lucrative market opportunities for radiation dose monitoring. Significant factors such as rapid urbanization, upgrade in healthcare infrastructure and delivery will further support the radiation dose monitoring market growth in emerging economies like India and China
• The market for radiation dose monitoring software is expected to generate strong revenue growth in the fiscal year 2015. The software market enables easy integration to existing architecture in healthcare facilities, and will sync into the integrated care delivery benefitting the specialists to provide better and monitored care
• The major market players recognized in this market are GE Healthcare, Sectra, Medicvision, Philips Healthcare, Toshiba MSC, Bayer AG, Landauer, Inc. and Thermo Fisher Scientific, Inc.

Grand View Research has segmented the global radiation dose monitoring market by component, application and product:

Radiation Dose Monitoring Component Outlook (Revenue, USD Million; 2014 - 2025)

• Software
• Service

Radiation Dose Monitoring Application Outlook (Revenue, USD Million; 2014 - 2025)

• Radiography
• Angiography
• Mammography
• Fluoroscopy & Interventional Imaging
• Others

Radiation Dose Monitoring Product Outlook (Revenue, USD Million; 2014 - 2025)

• Dosimeters
• Area Process Monitors
• Others

Radiation Dose Monitoring Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa
  • Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Osteosynthesis Devices Market Factors Hindering The Growth Rate, Challenges and Restraints For Business Development by 2024

The Report Osteosynthesis Devices Market Analysis By Type (Internal - Screws & Plates, Wires & Pins, Intramedullary Rods & Nails, Spinal Fixation Devices; External-Fracture Fixation, Bone Lengthening), By Material (Degradable & Non-degradable) And Segment Forecasts, 2018 - 2024

The osteosynthesis devices market size is expected to reach a value of USD 9.9 billion by 2024, according to a new report by Grand View Research, Inc. The worldwide prevalence of conditions like osteoporosis and osteomalacia, coupled with heavily occurring road traffic injuries/accidents and sporting injuries support the demand for osteosynthesis devices worldwide.

Osteoporosis, a disease resulting in weakening of bones is responsible for causing more than 8.9 million fractures annually. Forearm, humerus, hip and spine are the most commonly affected areas in patients suffering from the disease. The incidence and economic burden of osteoporosis is increasing worldwide, and patients 65 years old or over are at maximum risk of getting affected.

The geriatric population accounted for 46.2 million in 2014, and is increasingly rising. It is projected that by the year 2060, the number of older population will be twice than that of 2014. The rising incidence of osteoporosis and increasing count of the geriatric population is expected to drive demand for osteosynthesis devices in the coming years.

On the other hand, road traffic deaths are at the focal point of a crisis facing public health and development. The WHO reported that accidents/injuries majorly affect the low- and middle-income countries. Road accidents can cause severe injuries such as broken bones and fractures and requires immediate orthopediccare and attention. 

Access Research Report of Osteosynthesis Devices Market @ https://www.grandviewresearch.com/industry-analysis/osteosynthesis-devices-market

Further Key Findings from the Study Suggest:

• North America reported highest revenue growth in this market. U.S. is one of the most lucrative and commercially important markets for orthopedic device manufacturers. Furthermore, technical advancements and a growing aging population (14.5% of the U.S. population), coupled with increasing investments in healthcare sector is estimated to drive growth in the market.
• Asia Pacific is expected to be an attractive region for osteosynthesis devices. Asia Pacific is reported to be at a high risk for osteoporosis because of a reported rise in the elderly population.
• Internal fixation devices held a higher market share than external devices in 2015. Although complications such as infections, consolidation delays, and construct damage are causing concerns, this has indirectly led to the demand for new research and management options in the fight against osteoporosis and fractures.
• The development of absorbable and biocompatible internal bone fixation devices is responsible for leading the drive for constant innovation in the osteosynthesis devices market.
• Some of the key players in this industry include DePuy Synthes, Inc.; Smith & Nephew Plc; Stryker; Zimmer Biomet Holdings, Inc.; Globus Medical, Inc.; GS Medical, LLC; Life Spine, Inc.; MicroPort Orthopedics, Inc.; Néosteo SAS; and Precision Spine, Inc.

Grand View Research has segmented the osteosynthesis devices market by type and material:

Global Type Outlook (Revenue, USD Million, 2013 - 2024)

• Internal
• External

Global Material Outlook (Revenue, USD Million, 2013 - 2024)

• Degradable
• Nondegradable

Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dental Practice Management Software Market Soaring Demand Assures Motivated Revenue Share By 2026

The global dental practice management software market size is expected to reach USD 3.4 billion by 2026, based on a new report by Grand View Research, Inc., registering a 10.0% CAGR during the forecast period. Market growth can be attributed to increasing geriatric population and increase in oral healthcare expenditure.

According to the U.S. Census Bureau’s International Data Base, the population of individuals 45 years and older is expected to grow by about 12.0% between 2015 and 2025, while the total U.S. population will increase by about 8.0% during the same period. Furthermore, the expected increase in oral health insurance coverage and favorable government initiatives could drive the market during the forecast period.

Usage of various modules increases the productivity and efficiency of dentists. Furthermore, technological advancements in the field and growing investments by companies in emerging markets are expected to propel market growth. Integrated software with features such as appointment scheduling, reminder service, perio-charting, tooth charting, payment, and electronic health records helps streamline dental practice, which increases demand for the same.

Mergers and acquisitions for development and commercialization of products are likely to drive the market in the coming years. In June 2018, Patterson entered into a new joint venture with Cure Partners to form a new firm-Technology Partner Innovations, LLC-and launched NaVetor, a new cloud-based practice management software.

Access Research Report of Dental Practice Management Software Market @ https://www.grandviewresearch.com/industry-analysis/dental-practice-management-software-market

Further key findings from the study suggest:

• By deployment mode, the web-based segment dominated the market in 2018 as it provides some of the same features as cloud-based software and at lower costs as compared to other software. In addition, it enjoys the first-mover advantage in the market. However, the cloud-based segment may surpass the web-based and on-premises segments over the coming years owing to the additional advantages it offers
• The cloud-based dental practice management software segment is projected to grow at the fastest rate during the forecast period. This is due to its flexibility, disaster recovery system, automatic software updates, increased collaboration, ability to work on any internet connected device, security, environment-friendly features, and ability to establish competition
• In 2018, North America dominated the global market due to favorable government initiatives, local presence of key players, growing geriatric population, and high oral healthcare expenditure
• Asia Pacific is the fastest growing regional market owing to increasing investments by industry players and rising awareness about oral healthcare among people
• Some of the market players operating in the industry are Henry Schein, Inc.; Patterson Companies, Inc.; Carestream Dental; Curve Dental, Inc., DentiMax, LLC; Practice Web, Inc.; NextGenHealthcare Information Systems, LLC; and ACE Dental Software.

Grand View Research has segmented the global dental practice management software market by deployment mode and region:

Dental Practice Management Software Deployment Mode Outlook (Revenue, USD Million, 2015 - 2026)

• On-premise
• Web-based
• Cloud-based

Dental Practice Management Software Regional Outlook (Revenue, USD Million, 2015 - 2026)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
• Middle East and Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Immunohematology Market Plying for Significant Growth During the Forecast Period

The global immunohematology market size is expected to reach a value of USD 2.3 billion by 2024, according to a new report by Grand View Research, Inc. This expansion is attributed to the increasing cases of trauma and rising number of hospital and trauma care centers facilitating emergency treatments. This creates a need to procure blood to suffice the demand, thus, boosting the market for immunohematology tests and products.Involvement of government organizations and NGOs is vast in this field.

Use of technology is contributing to the growth in the market. Use of mobile applications helps in tracking the blood donation activity of volunteer donors and also reminds them to donate regularly. In April 2016, The Indian Red Cross Society launched an application (app) to facilitate blood banking facility. The app is expected to address the shortage issue in the region. Moreover, in 2011, the first type of this application was launched by Hemo bioscience, Inc., a U.S.-based company. The company made the app available for free for apple users.

Access Research Report of Immunohematology Market@
http://www.grandviewresearch.com/industry-analysis/immunohematology-market

Further Key Findings From the Study Suggest:

• Immunohematology reagents dominated the product segment in 2015 due to huge product variety and an increasing number of blood banks procuring these reagents. The innovations in the field are resulting in new product launches and also the efforts are acknowledged at a global level.
• In December 2013, Sysmex Corporation received the German Design Award for its XN-2000 hematology reagent. Almost 1,900 products were nominated for the award.
• Hospitals dominated the end-use segment in 2015 due to increasing number of emergency cases because of road accidents and other types of trauma. Governments and investors are increasingly investing in expanding and upgrading emergency departments in hospitals to cater to the growing demand and increase the chances of survival of trauma patients.
• In 2015, North America dominated the immunohematology market with a revenue share of more than 40%. In the U.S., there is a patient requiring transfusion every 2 seconds. The daily consumption of blood is approximately 36,000 units per day. This indicates the huge opportunity of growth in this region.
• Some of the key industry players are Hologic, Inc., Bio-Rad Laboratories, Inc.; Grifols, ThermoFisher, Immucor; Ortho Clinical Diagnostics; BD (Becton Dickinson); Siemens Healthcare GmbH; Abbott; and Beckman Coulter, Inc.

Grand View Research has segmented the global immunohematology market by product, enduse, and region:

Immunohematology Product Outlook (Market revenue in USD Million, 2013 - 2024)

• Immunohematology analyzer
• Immunohematology reagent

Immunohematology End-Use Outlook (Market revenue in USD Million, 2013 - 2024)

• Hospitals
• Blood banks
• Diagnostic laboratories

Immunohematology Regional Outlook (Market Revenue in USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Hospital Information Systems Market is Anticipated to Register 11.4% CAGR through 2025

The global hospital information systems (HIS) market is expected to reach USD 39.7 billion by 2025 according to a new report by Grand View Research, Inc. The growing demand to reduce the wastage of healthcare budgets, minimize the risk of errors, and streamline the workflow of hospitals for improved outcomes are the key contributors to the market expansion.

There is a paradigm shift from traditional approach of paper-based manual operations to paperless IT-based solutions in hospital management. The growing number of government initiatives across the globe is accelerating the deployment of such technology. In 2016, the National Governors Association Center for Best Practices Health Division published a roadmap with an aim of improving the exchange of critical health data across different health entities.

The IT companies and healthcare organizations are collaborating at a greater level to develop high utility services and products to improve overall hospital administration. For instance, IBM and Cleveland Clinic have announced their 5-year agreement to expand Cleveland Clinic’s health IT technologies. Another example is partnership between Hospira and Latric Systems to work toward developing two-way communication between EMRs andHospira's smart infusionpumps.

Technological advancements such as adoption of EHR, eHealth platforms, cloud computing, Picture Archiving and Communication System (PACS), Radiology Information Systems (RIS), web-based technology, Software as a Service (SaaS) are gaining momentum in the medical sector.

Access Research Report of Hospital Information Systems Market@ www.grandviewresearch.com/industry-analysis/hospital-information-systems-his-market

Further Key Findings from the Study Suggest:

• In 2015, cloud-based technology was the dominating segment owing to cost considerations and data storage capacity
• Software segment was the leading segment in 2015 due to growing need for IT infrastructure in hospital management
• North America dominated the market in 2015. The U.S. is the largest market in North America due to the high adoption of such systems as a result of government initiatives and sophisticated healthcare facilities
• Asia Pacific is expected to be the fastest growing owing to the improving infrastructure in the emerging economies, increasing government spending on healthcare, and rising adoption of advanced technologies
• The market dynamics indicate the presence of strong competition amongst the key players like Carestream Health; GE Healthcare; Philips Healthcare; Cerner Corporation; NextGen Healthcare; Merge Healthcare (IBM), and many others

Grand View Research has segmented the hospital information systems (HIS) market by delivery mode, component, and region:

HIS Delivery Mode Outlook (Market revenue in USD Billion, 2016 - 2025)

• Cloud-Based Technology
• On-Premises Installation
• Web-Based Technology

HIS Component Outlook (Market revenue in USD Billion, 2016 - 2025)

• Software
• Hardware
• Services

HIS Regional Outlook (Market revenue in USD Billion, 2016 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

General Surgery Devices Market Predicted to Witness Steady Growth During the Forecast Period

The global general surgery devices market size is expected to reach USD 26.5 billion by 2026 registering a CAGR of 8.5%, according to a new report by Grand View Research, Inc. Increasing number of surgical procedures being performed coupled with technological advancements is anticipated to drive the market. Moreover, rising awareness and patient affordability for plastic or reconstructive surgeries would propel the number of procedures conducted during the forecast period.

Global health initiatives for the advanced surgical procedure is expected to boost the market. In January 2017, Ethiopia Federal Ministry of Health (FMOH) launched the Health Sector Transformation Plan (HSTP) and Safe Surgery (SaLTS) program that prioritizes safe surgery and makes anesthesia care and emergency surgical services accessible and affordable.

Technological advancements are also contributing to the market growth. Several key companies are investing in R&D for the development of innovative products. For instance, development of medical robots to assist surgeons is a key advancement in the field. Medical robots offer several advantages, such as a 3D view of the operating field, reduced blood loss & transfusions, lower risk of infection, faster recovery time, minimal scarring, and high precision.

Furthermore, growing aging population and cases of road accidents and increased healthcare expenditure in emerging economies are likely to boost the market during the forecast period. According to the WHO, the world’s population aged 60 years and above is expected to reach 2 billion by 2050 from 900 million in 2015. Geriatric population is more susceptible to a number of diseases, which is likely to increase the need for effective treatments, thereby driving the market.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/general-surgery-devices-market

Further key findings from the study suggest:

• Disposable surgical supplies held the largest market share in 2018. Low product cost and regulatory support for the usage of disposable products is expected to fuel the demand for these devices
• Asia Pacific is estimated to expand at the highest CAGR over the forecast period due to technological advancements, increasing investments and improving reimbursement scenario along with the growing medical tourism sector in the region
• Medical robotics & computer-assisted surgery devices are projected to witness the maximum CAGR of 9.9% from 2019 to 2026 due to increasing R&D investments and availability of technologically advanced products
• Some of the key companies in the market are Medtronic plc; Johnson & Johnson Services, Inc.; CONMED Corp.; Becton, Dickinson and Company (BD); B Braun Melsungen AG; Strykers; Boston Scientific Corp.; Erbe Elektromedizin GmbH; and The 3M Company

Grand View Research has segmented the global general surgery devices market on the basis of type, application, and region:

General Surgery Devices Type Outlook (Revenue, USD Million, 2015 - 2026)

• Disposable Surgical Supplies
• Open Surgery Instrument
• Energy-based & Powered Instrument
• Minimally Invasive Surgery Instruments
• Adhesion Prevention Products
• Medical Robotics & Computer-assisted Surgery Devices

General Surgery Devices Application Outlook (Revenue, USD Million, 2015 - 2026)

• Orthopedic Surgery
• Cardiology
• Ophthalmology
• Wound Care
• Audiology
• Thoracic Surgery
• Urology & Gynecology Surgery
• Plastic Surgery
• Neurosurgery
• Others

General Surgery Devices Regional Outlook (Revenue, USD Million, 2015 - 2026)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Automotive LiDAR Market Top Companies, Trends and Growth Factors Details for Business Development by 2024

Add caption

The global automotive LiDAR market is expected to reach USD 223.2 million by 2024, according to a new report by Grand View Research, Inc. The surging acceptance of automobile safety application arenas and sophisticated technology incorporations in automobile driving automation are expected to boost the market growth. The increasing acceptance for semi-autonomous and autonomous cars in the years to come is further anticipated to bolster the market growth.

The market can be categorized, based on application types, into Advanced Driver Assistance Systems (ADAS) & autonomous cars. The ADAS application segment is further segregated into Automatic Emergency Braking (AEB) and Adaptive Cruise Control (ACC). The ADAS application segment is expected witness a significant growth, owing to the surging incorporation of forward-collision avoidance systems.Adaptive cruise control (ACC) is adiscretionary cruising choice for automobiles that robotically modifies the vehicle speed to retain a safe distance from vehicles ahead.The rising adoption of these systems in autonomous and semi-autonomous cars at various levels of automation is expected to draw huge ventures from the key participants, thus driving the regional market demand in the years to come.

In October 2016, Infineon Technologies AG (Germany) acquired Innoluce BV (The Netherlands), a fabless semiconductor company headquartered in Nijmegen. Infineon says it would develop chip components for high-performance LiDAR systems by utilizing Innoluce’s patented technology. This acquisition is expected to establish Infineon’s strong foothold as one of the automotive safety technologies vendors.

Want to Access Research Report of Automotive LiDAR Market Click the Link Below

http://www.grandviewresearch.com/industry-analysis/automotive-lidar-market

Further key findings from the report suggest:

• The global automotive LiDAR market is estimated to grow significantly over the forecast period due to the automation in the car safety technology, leading to reduced human efforts and increased efficiency
• Extensive R&D by market players,updated ratings of safety agencies and the increasing awareness, among consumers, have fueled the market growth assome major automakers have already started to integrate basic AEB systems as optional and standard options into their mass-market models
• The markets in the North American region including the U.S. & Canada and the European regions occupied a marginal proportion of the market share in 2015 on account of the administrative regulations mandating the installation of certain automotive safety technologies in both light weight and heavy weight vehicles in the region
• The key industry participants include Robert Bosch GmbH, Denso Corporation, Velodyne LiDAR, Inc., Novariant, Inc., LeddarTech, Continental AG, and Quanergy Systems, Inc.

Grand View Research has segmented the global automotive LiDAR market based on application type and regions:

LiDAR Application Type Outlook (Revenue, USD Million, 2014 - 2024)

• Advanced Driver Assistance Systems(ADAS)
  • Automatic Emergency Braking (AEB)
  • Adaptive Cruise Control (ACC)
• Autonomous Cars

LiDAR Regional Outlook (Revenue, USD Million, 2014 - 2024)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
• The Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Power Over Ethernet Market Pegged for Strong Growth by 2025

The global power over ethernet market is expected to reach USD 3.77 billion by 2025, according to a new report by Grand View Research, Inc. Rising demand of the cost effective and fast communication owing to increasing internet users is expected to drive the market growth over the forecast period. the increasing adoption of VoIP among the various application industry has also contributed to the market demand.

The rising deployment of the Ethernet-based RFID readers and security cameras is also expected to boost the market growth. Furthermore, the introduction of PoE Plus is further expected to contribute significantly toward the expansion of the application of technology in high power devices in the industry.

The increasing trend and demand of consumers for smart home automation and control for centrally managing the appliances and other electric systems has also contributed to the residential sector application growth, hence impacting the Power over Ethernet market in a positive manner.

The ability of the PoE of increasing the control, monitoring capabilities with the reduced costs and flexible network architectures across the various application segments has also contributed to the enhanced growth. Extensive adoption of the VoIP technology and rising demand for network security cameras are anticipated to drive the demand.

New launched applications and delivery systems enabling the users to switch to an IP service from a POTS offering a versatile platform is expected to drive the demand and focus of the VoIP over the forecast period. Furthermore, the rising energy costs and increasing adoption of the digital signage technology are also estimated to impel the PoE technology market demand.

Although, leveraging the technology benefits leads to higher capital expenditure on electrical and data infrastructure. further, in adequate supply of power and slow adoption rate of the technology can hamper the growth of the industry.

Access Research Report of Power Over Ethernet Market @ www.grandviewresearch.com/industry-analysis/power-over-ethernet-poe-market

Further key findings from the report suggest:

• The Power over Ethernet technology is gaining the attention within the market owing to the ability of combining the networking and electrical power into one cable
• The powered devices is expected to dominate the market with a share of over 50% in 2015
• Increasing implementation of IP cameras for security, webcams, VoIP phones are projected to lead the residential application growth
• North America is envisioned to emerge as a predominant region in terms of revenue over the forecast period owing to the increasing demand for ICs and PoE controllers
• The key industry players in the PoE market include Flexcomm Technology (China), Shenzhen Brothers Young Development Co. Ltd. (China), VISIX (U.S.), Maxim Integrated (U.S.)

Grand View Research has segmented the PoE market based on product type, application, and region:

PoE Product Outlook (Transaction Revenue, USD Billion, 2014 - 2025)

• Power Sourcing Equipment
• Powered Devices

PoE Application Outlook (Transaction Revenue, USD Billion, 2014 - 2025)

• Residential
• Commercial
• Industrial

PoE Regional Outlook (Transaction Revenue, USD Billion, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.